Sp891
MANAGEMENT OF HCC RECURRENCE AFTER LIVER TRANSPLANTATION
Date
May 8, 2023
Explore related products in the following collection:
Tracks
Related Products
RADIOEMBOLIZATION COMPARED TO CHEMOEMBOLIZATION AS FIRST LOCOREGIONAL TREATMENT IS ASSOCIATED WITH DECREASED LIVER TRANSPLANT WAITLIST DROPOUT FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA
BACKGROUND: The LI-RADS (Liver Reporting and Data Systems) was created to standardize reporting of CT/MR imaging for liver masses in cirrhosis patients at risk of hepatocellular carcinoma (HCC)…
TRANSJUGULAR INTRA HEPATIC PORTO SYSTEMIC SHUNT(TIPS) IN ADVANCED AGE;A NATIONAL DATABASE STUDY.
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
NON-INVASIVE PREDICTION OF HIGH-RISK ESOPHAGEAL VARICES VIA ELECTROCARDIOGRAM-BASED DEEP LEARNING MODEL
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
GLOBAL EPIDEMIOLOGY OF CIRRHOSIS: CHANGING ETIOLOGICAL BASIS AND DISEASE BURDEN BETWEEN FEMALES AND MALES
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…